General Information

NANETS is committed to furthering neuroendocrine tumor disease diagnosis, treatment and management through research and education. With over 22,000 new patients diagnosed with NETs each year, there is a continuing need to support NET research and advance the dissemination of vital research findings. NANETS' Multidisciplinary NET Medical Symposium represents an excellent opportunity to present research relevant to cutting edge topics in neuroendocrine tumor research. Medical researchers at institutions in North America and around the world are invited to submit abstracts for presentation. NANETS encourages abstract reporting on recent NET research and/or describing ongoing or current clinical trials with the intent of increasing awareness of these studies.

For reference in writing a successful abstract, please visit the NANETS Abstracts Library for examples.

This page contains important information. Please read before submitting.

  1. Requirements and Expections 
  2. Travel and Travel Grants
  3. Important Dates
  4. Acceptable Submissions
  5. The Review Process
  6. Step by Step Instructions for Online Submission

Requirements and Expectations

All presenters whose abstracts are accepted for oral presentation and/or the poster session are required to a) join NANETS and b) register for the 2023 Symposium. Please note that registration fees are discounted for NANETS members in good standing. Membership information may be found at

Oral presenters are expected to prepare and present a poster of the accepted abstract during the poster session at Symposium.

If no author listed on the abstract can present the poster at the symposium, the abstract must be withdrawn by September 4, 2023.

The presenting author must register and pay for the NANETS symposium no later than September 4, 2023 or the abstract will be pulled from the abstract book, poster session, and will not be published in Endocrine-Related Cancer (ERC) or on the NANETS website.

Back to Top

The Symposium is October 4-6, 0223 in Montreal, QC, Canada. By submitting an abstract, you are committing to attending the Symposium, if accepted.

Travel Grants
Up to 10 travel grants may be awarded to members of NANETS who have submitted a highly scored abstract. These grants may cover airfare, conference registration, ground transport, and overnight accommodations. You will have the opportunity to apply for a grant during the abstract submission process.

Presenting Authors who are also one of the following may apply for a travel grant: 

  • Graduate Students (must have a letter of support from the program director)
  • Fellows
  • Allied Healthcare Professionals
  • Post-Doctoral Fellows
  • Residents (must have a letter of support from the program director)
  • Junior Faculty (within 5 years of fellowship training or postgraduate appointment) 

Back to Top

Important Dates:

3/15/2023: Open call for abstracts

6/30/2023: Close abstract submissions (midnight Pacific Time)

On or about 8/4/2023: Abstract notifications sent

8/12/2023: Last day for authors to confirm their oral/poster presentations

Back to Top 

Acceptable Submissions

Investigators may submit abstracts that have been presented at other scientific meetings and/or published in scientific journals since October 1 of the prior year.

Categories for submission are:

    1. Basic Science
    2. Applied Basic Science
    3. Chemo/SSA/Biologics (Clinical)
    4. Nuclear Medicine/Interventional Radiology/Imaging (Clinical)
    5. Surgical/Applied Pathology (Clinical)
    6. Population Science
    7.  Other
    8. Trials in Progress


Back to Top

Review Process

Abstracts are reviewed and scored by NANETS’ Scientific Review & Research Committee of NET medical research experts, and selected to be shown in poster sessions or as oral abstract presentations at the NANETS Annual Multidisciplinary NET Medical Symposium, held each fall. Ten to twelve oral abstracts will be selected for presentation at Symposium.  

Possible outcomes of a submission:

1) Abstract is accepted for an oral presentation (poster presentation required); 2) Abstract is accepted as a Featured Poster during the Poster Session; 3) Abstract is accepted for the Poster Session at Symposium; 4) Abstract is rejected.

Publication of Abstracts
Accepted abstracts are published in an electronic Abstract Book, posted online in NANETS' Abstracts Library, and published in the NANETS affiliated medical journal, Endocrine-Related Cancer (ERC).

Back to Top 

Online Submission Portal

Abstracts must be submitted via our online system. Emails, photocopies or facsimile copies will not be accepted and will be discarded.

Once logged into the portal, select "NANETS 2023 Symposium" for Abstract Submissions.

Communication will go through the online abstract processing system. The submitter should be the presenting author or if you are submitting on behalf of the presenting author, you will need to add their contact information and list them as a presenter. It is the responsibility of the submitter to stay abreast of and relay vital communication to the team of authors.

Access the Abstract Submissions Portal HERE

Online Submission Information - Step by Step 

Profile Data

Please note: Even if you have used the submission portal for previous NANETS activities, additional information is now being collected in the profile data. You will need to review and update your profile information, or it will appear incomplete. Specifically, the “Institution type” and “Race” questions must be completed again for most users.


To start the submission process, you must agree to the following:

  1. I understand that NANETS has the right to publish all accepted abstracts in the Abstract Book.
  2. I understand that the submission of an abstract does not guarantee acceptance for presentation at the Annual Symposium.
  3. I understand that, if accepted for oral presentation, I must be a member of NANETS in good standing at the time of presentation.

Title and Category

Title: The title should clearly identify the contents of the abstract. Please do not identify the company or institution name in the title. Enter the title exactly as you would like it to appear. Titles are case-sensitive and must be twenty (20) or fewer words in length.

Category: Select the primary category for your abstract (see list above). Reviewers may modify the category after submission. You will be notified if this is the case.

Portal Profile

If you are the presenting author or are submitting on behalf of the presenting author, please create a portal account under the name of the presenting author. If you are a sub author, submitting on behalf of the presenting author, be prepared to submit your own CV and the CV of the main presenter.

All submissions will be required to upload a Resume, CV, or brief bio and complete a Continuing Education Agreement.

Edits can be made to your portal profile at any time.

Authors and Affiliations

Authors and Affiliations: Please include all non-presenting authors. Each author is entered on a separate line. First names should be complete and not just given as an initial. Each author may have up to two affiliations. Please make sure that if multiple authors share the same affiliation that the affiliation is entered exactly the same for each author.

First Author: Should be listed first. The author order in the abstract book will be based on the order you select.

Presenting Author: Please indicate which author will be the presenting author. If the presenting author is not registered to attend the conference, the abstract will be removed from the abstract book and Symposium program

Corresponding Author: All emails regarding the submission will be sent to the submitter. Additional emails can be added or edited during submission.

You are required to obtain the approval of all co-authors before placing their names on the abstract. Failure to do so will result in the immediate rejection of the abstract.

If submitting an abstract on behalf of someone else, you must add the presenting author’s name and contact information.

For first and senior authors, we will also ask if they are early career. This designation is important for the consideration of travel grants and awards. Early career is defined as: Graduate Students, Fellows, Allied Healthcare Professionals, Post-Doctoral Fellows, Residents, Junior Faculty (within 5 years of fellowship training or postgraduate appointment).

Conflict of Interest and Disclosures

NANETS must ensure balance, independence, objectivity, and scientific rigor in all individually provided or jointly provided educational activities. All individuals in a position to control the content of a CE activity (including faculty, planners, reviewers, or others) are required to disclose all relevant financial relationships with ineligible companies (commercial interests) in any amount for a period of 24 months prior to the start of the educational activity. Circumstances may create a conflict of interest when an individual has an opportunity to control content about products of ineligible companies (commercial interests) with which he or she has a relevant financial relationship. 

Disclosure Information

Have you had any relevant financial relationships in the last 24 months with an ineligible company (commercial interest)? "Ineligible companies are defined by the ACCME as those entities whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients.”

Abstract Content

The word limit for all four sections combined is 400 words. The word count does not include title, author names or institutions. One data table no larger than 10 rows x 5 columns is permitted per abstract and is counted in the word count.

Abstracts must include the following four sections:

  1. Background: The problem under investigation or an hypothesis.
  2. Methods: The experimental methods or protocols used to accomplish the research.
  3. Results: The key points derived from experiments.
  4. Conclusion: A summary of your findings that are supported by the data presented.

You can cut and paste text or type directly in the section boxes.


Tables must include a title, are restricted to conclusive findings and are limited to 10 single rows and 5 columns. Tables must be less than one-quarter the size of the complete abstract. Tables may not substitute for the required sections. Tables are included in the word count. Merged cells, shading and other formatting are not permitted. Reviewers reserve the right to request modified tables prior to publication. Figures and illustrations are not permitted.

Table Header - This is the overall title of the table and will be centered across all columns

Table Footer - This is the footer of the table and will be centered at the bottom of the table.

Do not include references. Any references included will be removed.


  1. NANETS Membership: Is the presenter a NANETS member? Select Yes/No/Not at present but will join prior to Symposium
  2. Prior Presentation: Has the primary author previously presented this abstract? If yes, enter details such as name, location and date.
  3. Early Career Status: For classification purposes (not eligibility): At the time of the 2023 NET Medical Virtual Symposium, will the presenting author be in training or in the first 5 years of initial faculty appointment at an accredited medical school or other institution in North America? Faculty appointments include instructors and above.
  4. IRB Approval: I certify that this study has been approved by any applicable oversight/ethics committee (e.g., IRB, EC, IACUC, etc.)

Travel Intentions

The Symposium is October 4-6, 2023 in Montreal, QC, Canada. By submitting an abstract, you are committing to attending the Symposium, if accepted. Please check your passport and other required travel documentation well in advance.

Travel Grant - Please refer to the travel grant specifications above.

  1. Select the type of travel grant, if any, you would like to be considered for.
  2. Enter the name of the travel grantee.
  3. Select the category of the traveler. Note that graduate students and residents are required to submit a letter of support from their program director.

Back to Top 


Questions can be directed to This email address is being protected from spambots. You need JavaScript enabled to view it..